Pteridine nucleotide analogs as fluorescent DNA probes
First Claim
Patent Images
1. A compound having the formula shown below, with ring vertices 1 through 8 as shown:
- ##STR25## in which;
R11 is combined with R12 to form a single oxo oxygen joined by a double bond to ring vertex 4, or with R13 to form a double bond between ring vertices 3 and 4;
R12 when not combined with R11 is a member selected from the group consisting of NH2, and NH2 either mono- or disubstituted with a protecting group;
R13 when not combined with R11 is lower alkyl or H;
R14 is a member selected from the group consisting of H, lower alkyl and phenyl;
R15 is combined with R16 to form a single oxo oxygen joined by a double bond to ring vertex 2, or with R17 to form a double bond between ring vertices 1 and 2, such that ring vertices 2 and 4 collectively bear at most one oxo oxygen;
R16 when not combined with R15 is a member selected from the group consisting of H, phenyl, NH2, and NH2 mono- or disubstituted with a protecting group;
when R15 is not combined with R16, R18 is combined with R19 to form a single oxo oxygen joined by a double bond to ring vertex 7;
when R15 is combined with R16, R18 is combined with R20 to form a double bond between ring vertices 7 and 8, and R19 is a member selected from the group consisting of H and lower alkyl; and
R17 when not combined with R15, and R20 when not combined with R18, are ##STR26## in which;
R21 is a member selected from the group consisting of H, a triphosphate, and protecting groups;
R22 is a member selected from the group consisting of H, OH and OH substituted with a protecting group; and
R23 is a member selected from the group consisting of H, a phosphoramidite, an H-phosphonate, a methyl phosphonate, a phosphorothioate, a phosphotriester, a hemisuccinate, a hemisuccinate covalently bound to a solid support, a dicyclohexylcarbodiimide, and a dicyclohexylcarbodiimide covalently bound to a solid support;
when R13 is H and R23 is H, R21 is a tfiphosphate; and
when R11 is combined with R13 to form a double bond between ring vertices 3 and 4 and R23 is H, R21 is a triphosphate.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides novel pteridine nucleotides which are highly fluorescent under physiological conditions and which may be used in the chemical synthesis of fluorescent oligonucleotidcs. The invention further provides for fluorescent oligonucleotides comprising one or more pteridine nucleotides. In addition the invention provides for pteridine nucleotide triphosphates which may be used as the constituent monomers in DNA amplification procedures.
511 Citations
85 Claims
-
1. A compound having the formula shown below, with ring vertices 1 through 8 as shown:
- ##STR25## in which;
R11 is combined with R12 to form a single oxo oxygen joined by a double bond to ring vertex 4, or with R13 to form a double bond between ring vertices 3 and 4;R12 when not combined with R11 is a member selected from the group consisting of NH2, and NH2 either mono- or disubstituted with a protecting group; R13 when not combined with R11 is lower alkyl or H; R14 is a member selected from the group consisting of H, lower alkyl and phenyl; R15 is combined with R16 to form a single oxo oxygen joined by a double bond to ring vertex 2, or with R17 to form a double bond between ring vertices 1 and 2, such that ring vertices 2 and 4 collectively bear at most one oxo oxygen; R16 when not combined with R15 is a member selected from the group consisting of H, phenyl, NH2, and NH2 mono- or disubstituted with a protecting group; when R15 is not combined with R16, R18 is combined with R19 to form a single oxo oxygen joined by a double bond to ring vertex 7; when R15 is combined with R16, R18 is combined with R20 to form a double bond between ring vertices 7 and 8, and R19 is a member selected from the group consisting of H and lower alkyl; and R17 when not combined with R15, and R20 when not combined with R18, are ##STR26## in which;
R21 is a member selected from the group consisting of H, a triphosphate, and protecting groups;R22 is a member selected from the group consisting of H, OH and OH substituted with a protecting group; and R23 is a member selected from the group consisting of H, a phosphoramidite, an H-phosphonate, a methyl phosphonate, a phosphorothioate, a phosphotriester, a hemisuccinate, a hemisuccinate covalently bound to a solid support, a dicyclohexylcarbodiimide, and a dicyclohexylcarbodiimide covalently bound to a solid support; when R13 is H and R23 is H, R21 is a tfiphosphate; and when R11 is combined with R13 to form a double bond between ring vertices 3 and 4 and R23 is H, R21 is a triphosphate. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85)
- ##STR25## in which;
Specification